tiprankstipranks
Advertisement
Advertisement

LEXX Stock Latest News

Lexaria Bioscience Corp trading halted, news pending
The FlyLexaria Bioscience Corp trading halted, news pending
1d ago
LEXX
Kneat Shareholders Strongly Back Thoma Bravo Acquisition Deal
PremiumCompany Announcements
Kneat Shareholders Strongly Back Thoma Bravo Acquisition Deal
3d ago
LEXX
Lexaria Bioscience announces effective date for reverse stock split
PremiumThe Fly
Lexaria Bioscience announces effective date for reverse stock split
3d ago
LEXX
Lexaria reports ‘positive’ meetings with potential partners at BIO convention
PremiumThe Fly
Lexaria reports ‘positive’ meetings with potential partners at BIO convention
27d ago
LEXX
Lexaria Bioscience ‘s human study GLP-1-H26-7 has begun dosing
PremiumThe Fly
Lexaria Bioscience ‘s human study GLP-1-H26-7 has begun dosing
1M ago
NVO
LEXX
Lexaria Bioscience begins dosing in animal study GLP-1-A26-1
PremiumThe FlyLexaria Bioscience begins dosing in animal study GLP-1-A26-1
1M ago
LEXX
Lexaria Bioscience provides update on GLP-1 oral pill market
Premium
The Fly
Lexaria Bioscience provides update on GLP-1 oral pill market
2M ago
LEXX
Lexaria announces dosing completion in 2026 Animal Study 2
Premium
The Fly
Lexaria announces dosing completion in 2026 Animal Study 2
2M ago
LEXX
Lexaria Bioscience announces ethics approval for Human Pilot Study 7
PremiumThe Fly
Lexaria Bioscience announces ethics approval for Human Pilot Study 7
2M ago
NVO
LEXX
Lexaria Bioscience provides update on Human Pilot Study #7
PremiumThe Fly
Lexaria Bioscience provides update on Human Pilot Study #7
3M ago
NVO
LEXX
Lexaria Bioscience extends material transfer agreement with pharma company
PremiumThe Fly
Lexaria Bioscience extends material transfer agreement with pharma company
3M ago
LEXX
Lexaria Bioscience launches new study to examine next-gen GLP-1 drugs
PremiumThe Fly
Lexaria Bioscience launches new study to examine next-gen GLP-1 drugs
3M ago
LEXX
Lexaria Bioscience provides update on GLP-1 oral pill market
PremiumThe FlyLexaria Bioscience provides update on GLP-1 oral pill market
3M ago
LEXX
Lexaria Launches New GLP-1 Study to Expand Drug Delivery IP
Premium
Company Announcements
Lexaria Launches New GLP-1 Study to Expand Drug Delivery IP
4M ago
LEXX
Lexaria Bioscience engages CRO for 2026 GLP-1-A26-1 study
Premium
The Fly
Lexaria Bioscience engages CRO for 2026 GLP-1-A26-1 study
4M ago
LEXX
Lexaria Eyes Growing Oral GLP-1 Market After Eli Lilly’s Foundayo Approval
PremiumCompany Announcements
Lexaria Eyes Growing Oral GLP-1 Market After Eli Lilly’s Foundayo Approval
4M ago
LEXX
Lexaria Bioscience ‘applauds’ Eli Lilly’s Foundayo drug approval
PremiumThe Fly
Lexaria Bioscience ‘applauds’ Eli Lilly’s Foundayo drug approval
4M ago
LLY
LEXX
Lexaria Launches New Human Trial to Advance Oral GLP-1 Drug Delivery Platform
PremiumCompany Announcements
Lexaria Launches New Human Trial to Advance Oral GLP-1 Drug Delivery Platform
4M ago
LEXX
Lexaria Bioscience to begin new human clinical study in GLP-1
PremiumThe Fly
Lexaria Bioscience to begin new human clinical study in GLP-1
4M ago
LEXX
Lexaria Bolsters Global Patent Portfolio With New GLP-1 and Cardiometabolic IP
PremiumCompany AnnouncementsLexaria Bolsters Global Patent Portfolio With New GLP-1 and Cardiometabolic IP
4M ago
LEXX
Lexaria receives five new patents, including two for diabetes treatment
Premium
The Fly
Lexaria receives five new patents, including two for diabetes treatment
4M ago
LEXX
Lexaria Targets Booming GLP-1 Market With Enhanced Oral Drug Platform
Premium
Company Announcements
Lexaria Targets Booming GLP-1 Market With Enhanced Oral Drug Platform
4M ago
LEXX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >